A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the ...
In total, CardieX won US$940,000 through the various phases of the competition ... but as validation from the largest ...
DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
A coalition of 12 Philadelphia-area health systems have abandoned the use of race adjustments in four clinical tools ...
BioNTech's Phase 3 NSCLC trial is paused after varying outcomes. Current participants continue treatment, and other trials ...
MERS stands for "Middle East respiratory syndrome"—causes severe respiratory diseases with a high mortality rate. To date, ...
Novo Nordisk is among global pharma leaders in the diabetes and weight loss segments. Read why I think NVO stock is a hold.
The University of California, San Diego (UCSD) is actively seeking participants for five ongoing clinical trials focused on ...
Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Medidata Rave Lite, an extension of the company’s gold-standard ...
SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...
Medical Treatments at the Dawn of AI: Why Drug Development Is Still Slow and How to Get Early Access
With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback